chr6-123393666-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006073.4(TRDN):c.1063G>T(p.Ala355Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000206 in 1,454,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1063G>T | p.Ala355Ser | missense_variant | 13/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.1066G>T | p.Ala356Ser | missense_variant | 13/21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.1006G>T | p.Ala336Ser | missense_variant | 12/20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1063G>T | p.Ala355Ser | missense_variant | 13/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 | |
TRDN-AS1 | ENST00000587106.6 | n.55+4191C>A | intron_variant, non_coding_transcript_variant | 5 | ||||||
TRDN | ENST00000662930.1 | c.1066G>T | p.Ala356Ser | missense_variant | 13/21 | ENSP00000499585 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000673 AC: 16AN: 237568Hom.: 0 AF XY: 0.0000776 AC XY: 10AN XY: 128836
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1454222Hom.: 0 Cov.: 30 AF XY: 0.0000263 AC XY: 19AN XY: 722812
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 10, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 355 of the TRDN protein (p.Ala355Ser). This variant is present in population databases (rs776657049, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 660929). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2024 | The p.A355S variant (also known as c.1063G>T), located in coding exon 13 of the TRDN gene, results from a G to T substitution at nucleotide position 1063. The alanine at codon 355 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at